Team:Hong Kong HKUST/data
From 2013.igem.org
(Difference between revisions)
(Created page with "<div class="menu"> <ul class="first"> <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST">Home</a></li> <li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/team">Team</a...") |
|||
(36 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | <html> | ||
+ | <head> | ||
+ | <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"> | ||
+ | </script> | ||
+ | |||
+ | <script type="text/javascript"> | ||
+ | $(document).ready(function(){ | ||
+ | $("ul.first > li").hover(function(){ | ||
+ | $(this).find("ul").stop().fadeToggle(10); | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
+ | |||
+ | <script> | ||
+ | $(document).ready(function() | ||
+ | { | ||
+ | $('#menubar').mouseover(function(){ | ||
+ | $('#menubar').stop().animate({top:"0px"},500); | ||
+ | }); | ||
+ | $('#menubar').mouseleave(function(){ | ||
+ | $('#menubar').stop().animate({top:"-20px"},500); | ||
+ | }); | ||
+ | $('#menubar.right-menu').mouseover(function(){ | ||
+ | $('#menubar.right-menu').stop().animate({top:"0px"},500); | ||
+ | }); | ||
+ | $('#menubar.right-menu').mouseleave(function(){ | ||
+ | $('#menubar.right-menu').stop().animate({top:"-20px"},500); | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
+ | <style type="text/css"> | ||
+ | body{background-color:#494042;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;height:100%;} | ||
+ | #menubar | ||
+ | {background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;} | ||
+ | #menubar ul li a | ||
+ | { color:#8D1919;} | ||
+ | #menubar.right-menu | ||
+ | {background-color:#EEECEC;opacity:0.8;top:-4px;width:240px;height:23px;position:absolute;top:-20px;} | ||
+ | .right-menu li a | ||
+ | {color:#8D1919;background-color:#EEECEC;} | ||
+ | #p-logo | ||
+ | {visibility:hidden;} | ||
+ | .firstHeading | ||
+ | {visibility:hidden;} | ||
+ | #globalWrapper | ||
+ | {position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;} | ||
+ | #content | ||
+ | {width: 1000px;border:none;background-color:#494042;padding:0px;margin-top:0px;line-height: 1.5em;color: black;} | ||
+ | #top-section | ||
+ | {height:2px;border:none;background-color:#494042;} | ||
+ | #catlinks | ||
+ | {border-color:#494042;background-color:#494042;} | ||
+ | #footer-box | ||
+ | {display:none} | ||
+ | #kepala | ||
+ | {position:absolute;top:15px;background-color:#F0A5BE;height:121px;width:100%;} | ||
+ | #copyright | ||
+ | {position:absolute;left:325px;top:630px;} | ||
+ | .menu ul,li | ||
+ | { | ||
+ | margin:0; | ||
+ | padding:0; | ||
+ | list-style:none; | ||
+ | width:100%; | ||
+ | } | ||
+ | ul.first>li | ||
+ | { | ||
+ | float:left; | ||
+ | width:16.66%; | ||
+ | } | ||
+ | ul.first>li>a:link,ul.first>li>a:visited | ||
+ | { | ||
+ | display:block; | ||
+ | font-weight:bold; | ||
+ | color:#494042; | ||
+ | background-color:#35bb91; | ||
+ | text-align:center; | ||
+ | padding:3%; | ||
+ | text-decoration:none; | ||
+ | text-transform:uppercase; | ||
+ | } | ||
+ | |||
+ | ul.first>li>a:hover,ul.first>li>a:active | ||
+ | { | ||
+ | background-color:#e32e51; | ||
+ | } | ||
+ | |||
+ | ul.first>li>ul | ||
+ | { | ||
+ | display:none; | ||
+ | width:100%; | ||
+ | } | ||
+ | |||
+ | ul.first>li>ul>li>a:link,ul.first>li>ul>li>a:visited | ||
+ | { | ||
+ | display:block; | ||
+ | font-weight:bold; | ||
+ | color:#494042; | ||
+ | background-color:#8ff5d5; | ||
+ | text-align:center; | ||
+ | padding:3%; | ||
+ | text-decoration:none; | ||
+ | text-transform:uppercase; | ||
+ | } | ||
+ | |||
+ | ul.first>li>ul>li>a:hover,ul.first>li>ul>li>a:active | ||
+ | { | ||
+ | background-color:#f87790; | ||
+ | } | ||
+ | .menu | ||
+ | { | ||
+ | position:absolute; | ||
+ | left:0px; | ||
+ | top:141px; | ||
+ | width:100%; | ||
+ | } | ||
+ | ul, ol { | ||
+ | line-height: 1.6; | ||
+ | font-size: 14px; | ||
+ | } | ||
+ | #slide{width:96%;height:auto;background-color:#F4DFC0;margin-top:80px;border:2px solid; | ||
+ | border-radius:15px;padding-right:20px;margin-left:0px;padding-left:20px;font-family:"Trebuchet MS",Helvetica,sans-serif;} | ||
+ | .center | ||
+ | { | ||
+ | margin:auto; | ||
+ | width:70%; | ||
+ | background-color:#b0e0e6; | ||
+ | } | ||
+ | #interview, #article, #interview1, #presentation1,#article1 | ||
+ | {margin-top:20px;width:48%;float:left;height:auto; border:2px solid; | ||
+ | border-radius:15px;font-family:"Trebuchet MS", Helvetica, sans-serif;padding-bottom:15px;} | ||
+ | #presentation{margin-top:20px;width:48%;float:right;height:auto; border:2px solid; | ||
+ | border-radius:15px;font-family:"Trebuchet MS", Helvetica, sans-serif;padding-bottom:15px;} | ||
+ | #interview | ||
+ | {background:#e32e51;} | ||
+ | #interview1 | ||
+ | {background:#35bb91;} | ||
+ | #presentation,#article1 | ||
+ | {background:#35bb91;margin-left:20px;} | ||
+ | #article,#presentation1 | ||
+ | {background:#000000;} | ||
+ | #art-desc,#pre-desc,#int-desc{width:50%;float:right;margin-right:8px;} | ||
+ | #art-img,#pre-img,#int-img{width:45%;float:left;margin-left:5px;} | ||
+ | #art-desc-text,#pre-desc-text,#int-desc-text{float:right;} | ||
+ | h3,h1,#yo{margin-left:10px;font-family:"Trebuchet MS", Helvetica, sans-serif;} | ||
+ | h3.title{font-size:40px;} | ||
+ | #hey{font-size:28px;margin-left:10px;font-family:"Trebuchet MS", Helvetica, sans-serif;} | ||
+ | |||
+ | #iGEM_Logo{ | ||
+ | width:100px; | ||
+ | height:80px; | ||
+ | position:absolute; | ||
+ | right:10px; | ||
+ | top:60px; | ||
+ | z-index:+15; | ||
+ | } | ||
+ | #hkust_Logo{ | ||
+ | width:60px; | ||
+ | height:80px; | ||
+ | position:absolute; | ||
+ | right:110px; | ||
+ | top:60px; | ||
+ | z-index:+15; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
+ | |||
+ | <a href="https://2013.igem.org/Main_Page"><img id="iGEM_Logo" src="https://static.igem.org/mediawiki/2013/4/46/Igem_qgem_logo.png"></a> | ||
+ | |||
+ | |||
+ | <a href="http://www.ust.hk/eng/index.htm"><img id="hkust_Logo" src="https://static.igem.org/mediawiki/2013/5/55/Hkust_logo.gif"></a> | ||
+ | |||
+ | <a href=https://2013.igem.org/Team:Hong_Kong_HKUST><center><div id="kepala"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;"></div></center></a> | ||
+ | |||
<div class="menu"> | <div class="menu"> | ||
<ul class="first"> | <ul class="first"> | ||
Line 56: | Line 232: | ||
</div> | </div> | ||
+ | |||
+ | <br><br><br><div id="slide"><center><h3 class="title">Data Page</h3></center><br> | ||
+ | |||
+ | <p><font size=3><i>This page shows all the parts we have made or used in our whole project. Click on the links below to see our constructs on the Registry of Standard Biological Parts in detail. Click <a href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">here</a> to access our result page for an overview of our achievements with those parts.</i></font> | ||
+ | <br><br> | ||
+ | <h3>How our system works:</h3><br> | ||
+ | <center><img src="https://static.igem.org/mediawiki/2013/7/72/Datapage_cell1_copy.png" style="width:70%;"></center> | ||
+ | <br><br> | ||
+ | <h3>Data For Our Favorite New Parts:</h3> | ||
+ | <ul> | ||
+ | <li><strong>Mitochondrial leader sequence, <a href="http://parts.igem.org/Part:BBa_K1119001">BBa_K1119001</a></strong>: for directing proteins to the mitochondria. When the mitochondrial leader sequence is attached, glyoxylate enzymes AceA and AceB can be led into mitochondria to facilitate glyoxylate shunt.</li> | ||
+ | <li><strong>Cytomegalovirus promoter (CMV Promoter), <a href="http://parts.igem.org/Part:BBa_K1119006">BBa_K1119006</a></strong>: constitutive mammalian promoter. With the CMV promoter, constitutive expression of the glyoxylate genes <i>aceA</i> and <i>aceB</i> can be realized.</li> | ||
+ | <li><strong>Human Elongation Factor-1alpha promoter (EF-1alpha Promoter), <a href="http://parts.igem.org/Part:BBa_K1119006">BBa_K1119010</a></strong>: constitutive mammalian promoter. With the EF-1alpha promoter, constitutive expression of the glyoxylate genes <i>aceA</i> and <i>aceB</i> can be realized.</li> | ||
+ | </ul> | ||
+ | <br><br> | ||
+ | <h3>Data for Pre-existing Parts:</h3> | ||
+ | <ul> | ||
+ | <li><strong>Kozak-XbaI-NLS-6His-Stop, <a href="http://parts.igem.org/Part:BBa_J176171">BBa_J176171</a></strong> (Haynes Lab, 2007): used as a backbone for P<sub><i>fadBA </i></sub>and P<sub><i>fabp1</i></sub>.</li> | ||
+ | <li><strong>hGH-PolyA, </strong><strong><a href="http://parts.igem.org/Part:BBa_K404108">BBa_K404108</a></strong></a><strong> </strong>(Freiburg Bioware iGEM, 2010): hGH PolyA tail was added after the GFP sequence in the construct of <strong><a href="http://parts.igem.org/Part:BBa_K1119008">BBa_K1119008 </a></strong>and<strong> <a href="http://parts.igem.org/Part:BBa_K1119009">BBa_K1119009</a> </strong>for characterization of MLS, which gave us the expected results.</li> | ||
+ | <li><strong>GFP <a href="http://parts.igem.org/Part:BBa_K648013">BBa_K648013</a></strong>(Penn-State iGEM, 2011): green fluorescent protein reporter (<a href="http://parts.igem.org/Part:BBa_E0040"><b>BBa_E0040</b></a>) with RFC 25 assembly standard prefix and suffix was used as a reporter for characterization of MLS and the CMV promoter.</li> | ||
+ | </ul> | ||
+ | <br><br> | ||
+ | <h3>We Also Characterized the Following Parts</h3> | ||
+ | <ul> | ||
+ | <li><strong>CMV promoter-GFP, <a href="http://parts.igem.org/Part:BBa_K1119008">BBa_K1119008</a>: </strong>CMV promoter was assembled with GFP-hGH PolyA. Following transfection of the construct into HEK293FT cells, GFP was successfully expressed.</li> | ||
+ | <li><strong>CMV promoter-Mitochondrial Leader Sequence fused with GFP , <a href="http://parts.igem.org/Part:BBa_K1119009">BBa_K1119009</a></strong>: CMV promoter assembled with MLS and GFP-hGH PolyA. Following transfection of the construct into HEK293FT cells, GFP was successfully expressed and directed into mitochondria.</li> | ||
+ | <li><strong>EF-1alpha promoter-GFP, <a href="http://parts.igem.org/Part:BBa_K1119011">BBa_K1119011</a>: </strong>EF-1alpha promoter was assembled with GFP-hGH PolyA. Following transfection of the construct into HEK293FT cells, GFP was successfully expressed.</li> | ||
+ | </ul> | ||
+ | <br><br><br> | ||
+ | </p> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | |||
+ | </body> | ||
+ | |||
+ | </html> |
Latest revision as of 13:20, 28 October 2013
Data Page
This page shows all the parts we have made or used in our whole project. Click on the links below to see our constructs on the Registry of Standard Biological Parts in detail. Click here to access our result page for an overview of our achievements with those parts.
How our system works:
Data For Our Favorite New Parts:
- Mitochondrial leader sequence, BBa_K1119001: for directing proteins to the mitochondria. When the mitochondrial leader sequence is attached, glyoxylate enzymes AceA and AceB can be led into mitochondria to facilitate glyoxylate shunt.
- Cytomegalovirus promoter (CMV Promoter), BBa_K1119006: constitutive mammalian promoter. With the CMV promoter, constitutive expression of the glyoxylate genes aceA and aceB can be realized.
- Human Elongation Factor-1alpha promoter (EF-1alpha Promoter), BBa_K1119010: constitutive mammalian promoter. With the EF-1alpha promoter, constitutive expression of the glyoxylate genes aceA and aceB can be realized.
Data for Pre-existing Parts:
- Kozak-XbaI-NLS-6His-Stop, BBa_J176171 (Haynes Lab, 2007): used as a backbone for PfadBA and Pfabp1.
- hGH-PolyA, BBa_K404108 (Freiburg Bioware iGEM, 2010): hGH PolyA tail was added after the GFP sequence in the construct of BBa_K1119008 and BBa_K1119009 for characterization of MLS, which gave us the expected results.
- GFP BBa_K648013(Penn-State iGEM, 2011): green fluorescent protein reporter (BBa_E0040) with RFC 25 assembly standard prefix and suffix was used as a reporter for characterization of MLS and the CMV promoter.
We Also Characterized the Following Parts
- CMV promoter-GFP, BBa_K1119008: CMV promoter was assembled with GFP-hGH PolyA. Following transfection of the construct into HEK293FT cells, GFP was successfully expressed.
- CMV promoter-Mitochondrial Leader Sequence fused with GFP , BBa_K1119009: CMV promoter assembled with MLS and GFP-hGH PolyA. Following transfection of the construct into HEK293FT cells, GFP was successfully expressed and directed into mitochondria.
- EF-1alpha promoter-GFP, BBa_K1119011: EF-1alpha promoter was assembled with GFP-hGH PolyA. Following transfection of the construct into HEK293FT cells, GFP was successfully expressed.